https://www.thehindubusinessline.com/companies/generic-versions-of-novo-nordisks-semaglutide-begin-to-flow-priced-50-80-lower-than-the-innovator/article70769849.ece ...

Novo Nordisk AS has slashed prices of its blockbuster weight-loss drugs Ozempic and Wegovy in India, amid an onslaught of copycat drugs in the world's third most overweight population. Many patients ...

Two-time cancer survivor Sherman McDaniel may be in fragile health, but she is sticking to her vow: “I’m not going anywhere until Generic Theater has a permanent home. Until then, I will not die.” ...

Did our AI summary help? Hetero has begun exporting generic versions of semaglutide, accelerating competition in the global market for diabetes and obesity medicines as demand for GLP‑1 therapies ...

Danish pharmaceutical giant Novo Nordisk on Tuesday announced price cuts of up to 48% on its blockbuster diabetes and obesity drugs Ozempic and Wegovy in India, weeks after semaglutide—the active ...

A drug that helped turn Novo Nordisk into Europe's most valuable company is about to lose its monopoly grip across much of the globe. Patent protections on semaglutide—sold as Ozempic for diabetes and ...

Did our AI summary help? Novo Nordisk on Tuesday slashed prices of its blockbuster diabetes and obesity drugs Ozempic and Wegovy in India, to defend its hold after the launch of multiple low-cost ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

New Delhi [India], April 5 (ANI): US President Donald Trump has announced a sweeping 100 per cent tariff on select pharmaceutical imports, a move that comes shortly after a Jefferies report flagged ...

Alkem’s semaglutide pen devices will be marketed under the brand names Semasize, Obesema, and Hepaglide. Alkem Laboratories is positioning itself to lead India’s fast-growing weight-loss drug market, ...

The day before semaglutide went off-patent in India, Danish drug maker Novo Nordisk got US Food and Drug Administration approval for a higher-dose version of Wegovy, its blockbuster weight loss drug ...